spotlightOzempic, Wegovy and Mounjaro: Why Ireland is struggling to fund the new weight-loss drugsNew weight-loss drugs promise transformative benefits, but soaring demand and massive cost projections leave Ireland facing difficult funding choices
comment-analysisChildren’s science museum: How a 20-year €70m plan became a political ‘omnishambles’